Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.280
+0.010 (0.79%)
May 6, 2026, 2:23 PM EDT - Market open

Pulmonx Revenue

Pulmonx had revenue of $20.59M in the quarter ending March 31, 2026, a decrease of -8.66%. This brings the company's revenue in the last twelve months to $88.55M, up 1.23% year-over-year. In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth.

Revenue (ttm)
$88.55M
Revenue Growth
+1.23%
P/S Ratio
0.61
Revenue / Employee
$299,139
Employees
296
Market Cap
54.06M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202590.50M6.71M8.01%
Dec 31, 202483.79M15.11M22.01%
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 202032.73M138.00K0.42%
Dec 31, 201932.60M12.59M62.94%
Dec 31, 201820.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Accuray436.97M
TELA Bio80.28M
LENSAR58.44M
electroCore32.03M
Sensus Healthcare27.48M
Baird Medical Investment Holdings22.54M
Elutia12.29M
InspireMD10.85M
Revenue Rankings